AI assistant
Sending…
Lexaria Bioscience Corp. — Director's Dealing 2009
Jun 15, 2009
34983_dirs_2009-06-15_ff5eb2f2-3634-4635-b038-5943f5ab520e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEXARIA CORP. (LXRA)
CIK: 0001348362
Period of Report: 2009-06-11
Reporting Person: BUNKA CHRISTOPHER (Director, Chairman/CEO/President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-06-11 | Common Shares | P | 25900 | $0.04 | Acquired | 1390350 | Indirect |
| 2009-06-11 | Common Shares | P | 162500 | $0.01 | Acquired | 1552850 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares | 863600 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants | $0.6 | 2009-11-09 | Common Shares (1116800) | 1116800 | Indirect |
| Stock Options | $0.8 | 2011-04-26 | Stock Options (400000) | 400000 | Direct |
| Stock Options | $0.12 | 2011-07-20 | Common Shares (400000) | 400000 | Direct |
Footnotes
F1: Chris Bunk is tyhe sole owner of CAB Financial Services Ltd.
F2: On June 19, 2007, the exercise price was reduced from $1.30
More from Lexaria Bioscience Corp.
Interim / Quarterly Report
2026
Apr 13
Director's Dealing
2026
Mar 18
Delisting Announcement
2026
Feb 6
Regulatory Filings
2026
Jan 28
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 28
Capital/Financing Update
2026
Jan 14
Delisting Announcement
2026
Jan 14
Interim / Quarterly Report
2026
Jan 13
Capital/Financing Update
2025
Dec 29
Regulatory Filings
2025
Dec 19